statistiche ricercatore

Nome	#
Does oral alpha lipoic acid prevent oxaliplatin-induced peripheral neuropathy? A randomized, double-blind, parallel-arm, placebo-controlled trial	56
Total and high molecular weight adiponectin expression is decreased in patients with common variable immunodeficiency: Correlation with Ig replacement therapy	34
S43ZeOxaNMulti trial: a randomized, double-blinded, placebo-controlled trial of oral zeolite “Multizeo Med” (based on PMA-zeolite – a double activated zeolite clinoptilolite called also Panalite) to prevent chemotherapy-induced side effects, in particular peripheral neuropathy	32
A Blood Test for the Diagnosis of Multiple Sclerosis	12
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry	12
Totale	146

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	11	0	0	0	0	0	2	0	0	1	2	6	0
2020/2021	18	4	0	0	0	7	0	0	0	0	0	3	4
2021/2022	16	0	0	0	0	0	0	1	2	0	2	4	7
2022/2023	32	6	1	2	1	4	4	0	7	4	0	2	1
2023/2024	22	2	2	0	1	0	7	0	3	0	0	5	2
2024/2025	32	9	6	1	7	9	0	0	0	0	0	0	0
Totale													146